Clinical pharmacokinetics and interaction of centchroman - A mini review

Contraception

Volumn 81, Issue 4, 2010, Pages 275-280

  Lal, Jawahar ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

Centchroman; Drug drug interaction; Ormeloxifene; Pharmacokinetics; Selective estrogen receptor modulator

Indexed keywords

7 DESMETHYLCENTCHROMAN; CENTCHROMAN; DRUG METABOLITE; LACTIC ACID; TETRACYCLINE; UNCLASSIFIED DRUG;

AREA UNDER THE CURVE; CLINICAL TRIAL; DRUG ABSORPTION; DRUG BINDING; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG MECHANISM; DRUG METABOLISM; FEMALE; FLUORESCENCE ANALYSIS; HUMAN; LACTIC ACID BACTERIUM; LIQUID CHROMATOGRAPHY; MAXIMUM PLASMA CONCENTRATION; METRORRHAGIA; REVIEW; SINGLE DRUG DOSE; TISSUE DISTRIBUTION;

ANIMALS; CENTCHROMAN; CONTRACEPTIVES, ORAL; CONTRACEPTIVES, POSTCOITAL, SYNTHETIC; DRUG INTERACTIONS; FEMALE; HUMANS; INDIA; RATS; UTERINE HEMORRHAGE;

EID: 77949275102     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2009.11.007     Document Type: Review

References (69)

1. Ray S., Kamboj V., Grover P., Kar A., and Anand N. A process for the synthesis of 2,2-disubstituted-3,4-diphenylchromans (1975) Indian Patent Specification No. 129187
2. WHO. Proposed international nonproprietary names: List 69. WHO Drug Inf 7 (1993) 87
3. Nityanand S., and Anand N. Centchroman: a nonsteroidal antifertility agent. FOGSI (Fed Obstet Gynaecol Soc, India) FOCUS (1996) 8-10
4. Nityanand S. Centchroman: current status as a contraceptive. Proc X Indian Conf Family Welfare Voluntary Sterilization, Jimpur, Pondicherry, India, August 19-21 (1994) 41-42
5. Kamboj V.P., Ray S., and Dhawan B.N. Centchroman. Drugs Today 28 (1992) 227-232
6. Nityanand S., Wati C., Singh L., Srivastava J.S., and Kamboj V.P. Clinical evaluation of centchroman: a new oral contraceptive. In: Puri C.P., and VanLook P.F.A. (Eds). Hormone antagonists for fertility regulation (1988), Indian Soc Study Reprod Fert, India, Bombay 223-230
7. Nityanand S., Kamboj V.P., Wati C., et al. Contraceptive efficacy and safety of centchroman with biweekly-cum-weekly schedule. In: Puri C.P., and VanLook P.F.A. (Eds). Current concepts in fertility regulation and reproduction (1994), Wiley Eastern Ltd, New Delhi 61-68
8. Nityanand S., Gupta R.C., Kamboj V.P., Srivastava P.K., and Berry M. Centchroman: current status as a contraceptive. In: Dawn S.C., and Misra A. (Eds). Indian progress in family welfare: Clinical research on maternal and child health and contraception (1995), Dawn Books, Calcutta 26-31
9. Puri V., Kamboj V.P., Chandra H., et al. Results of multicentric trial of centchroman. In: Dhawan B.N., Agarwal K.K., Arora R.B., and Parmar S.S. (Eds). Pharmacology for health in Asia (1988), New Delhi, Allied Publishers 439-447
10. Rajpal M., and Rajpal V.K. Efficacy and safety of centchroman in clinical practice: a retrospective study. Proc X Indian Conf Family Welfare Voluntary Sterilization, Jimpur, Pondicherry, India, 19-21, August (1994) 21
11. Rajan R. Contraceptive and non-contraceptive benefits of centchroman. Asian J Obstet Gynaecol 1 (1996) 65-71
12. Rajan R. Contraceptive and non-contraceptive benefits of centchroman. Proceedings of the International Meeting on Safe Motherhood, Guwahati, India (1996) 94-99
13. Rajan R. Contraceptive and non-contraceptive benefits of centchroman. In: Rajan R. (Ed). Reproductive endocrinology (1997), New Delhi, Jaypee Brothers 487-497
14. Jordan V.C. Biochemical pharmacology of antiestrogen action. Pharmacol Rev 36 (1984) 245-276
15. Grubb G.S. Experimental methods of contraception. Curr Opin Obstet Gynecol 3 (1991) 491-495
16. Yuzpe A.A. Post-coital contraception. In: Corson S.L., Derman R.J., and Tyrer L.B. (Eds). Fertility control (1985), Little Brown and Company, Boston, MA 289-297
17. Macgregor J.J., and Jordan V.C. Basic guide to the mechanism of antiestrogen action. Pharm Rev 50 (1998) 151-196
18. Kamboj V.P., Kar A.B., Ray S., Grover P.K., and Anand N. Antifertility activity of 3-4-trans-2,2-dimethyl-3-phenyl-4-[4-(β-pyrolidinoethoxy)phenyl]-7-methoxychromans. Indian J Exp Biol 9 (1971) 103-105
19. Kamboj V.P., Setty B.S., Chandra H., Roy S.K., and Kar A.B. Biological profile of centchroman- a new post-coital contraceptive. Indian J Exp Biol 15 (1977) 1141-1150
20. Singh M.M., Bhalla V., Wadhwa V., and Kamboj V.P. Effect of centchroman on tubal transport and pre-implantation embryonic developments in rats. J Reprod Fertil 76 (1986) 317-324
21. Singh M.M., and Kamboj V.P. Fetal resorption in rats treated with an antiestrogen in relation to luteal phase nidatory estrogen secretion. Acta Endocr 126 (1992) 444-450
22. Singh M.M., Sreenivasulu S., and Kamboj V.P. Duration of anti-implantation action of a triphenylethylene antiestrogen centchroman in adult female rats. J Reprod Fertil 100 (1994) 367-374
23. Indian Pharmacopoeia. Centchroman (1996), The Controller of Publications, Delhi 539-540
24. The Merck Index. In: Budavari S. (Ed). Centchroman. 12th ed (1996), 7 Merck Co. Inc, Whitehouse Station, NJ 327
25. Singh M.M. Centchroman, a selective estrogen receptor modulator, as a contraceptive and for the management of hormone-related clinical disorders. Med Res Rev 21 (2001) 302-347
26. Trivedi R.N., Chauhan S.C., Dwivedi A., Maitra S.C., Kamboj V.P., and Singh M.M. Time related effects of a triphenylethylene antiestrogen on estrogen induced changes in uterine weight, estrogen receptors and endometrial sensitivity in immature rats. Contraception 51 (1995) 367-379
27. Chauhan S.C., Singh M.M., Maitra S.C., and Kamboj V.P. Inhibition of progesterone induced development of giant mitochondria in uterine glandular epithelial cells by an antiestrogen in rat. Contraception 54 (1996) 259-264
28. Singh M.M., Chauhan S.C., Maitra S.C., Trivedi R.N., and Kamboj V.P. Correlation of pinopod development on uterine luminal epithelial surface with hormonal events and endometrial sensitivity in rat. Eur J Endocr 135 (1996) 107-117
29. Singh M.M., Trivedi R.N., Chauhan S.C., Srivastava V.M.L., and Kamboj V.P. Uterine estradiol and progesterone receptor concentration, activities of certain antioxidant enzymes and dehydrogenases and histoarchitecture in relation to time of secretion of nidatory estrogen and high endometrial sensitivity in rat. J Steroid Biochem Mol Biol 59 (1996) 215-224
30. Bansode F.W., Chauhan S.C., Makke A., and Singh M.M. Uterine luminal epithelial alkaline phosphatase activity and pinopod development in relation to endometrial sensitivity in rat. Contraception 58 (1998) 61-68
31. CDRI. Centchroman: antineoplastic, antiestrogen. Drugs Fut 16 (1991) 654
32. Iyer S.S. India launches the new weekly contraceptive pill. Drug News Perspect 4 (1991) 228-229
33. Misra N.C., Nigam P.K., Gupta R., Aggarwal A.K., and Kamboj V.P. Centchroman-a nonsteroidal anticancer agent for advanced breast cancer-Phase II study. Int J Cancer 43 (1989) 781-783
34. Piggott JM. 3,4-Diarylchromans for treatment of dermatitis. Zymogenetics, Seattle, WA, US Patent 5451603.
35. Labroo VM, Piggott JR, Bain SD, Methods for reducing bone loss using centchroman derivatives. Zymogenetics, Seattle, WA US Patent 5280040.
36. Bryant HU, Dodge JA, Methods for lowering cholesterol and inhibiting smooth muscle proliferation, restenosis, endometriosis, and uterine fibroid disease. Eli Lilly, Indianapolis, IN US Patent 5407955.
37. Nair R.K., Sheyte T.A., and Munshi S.R. Progestational and antiprogestational effects of centchroman in mouse and rabbit. Indian J Exp Biol 15 (1977) 1157-1158
38. Mehrotra P.K., and Nilsson B.O. Ultrastructural effects of the nonsteroidal contraceptive centchroman on rat uterine luminal epithelium in early pregnancy. Int J Fertil 29 (1984) 44-53
39. Roy S.N., Kumari G.L., Modoiya K., Prakash V., and Ray S. Induction of ovulation in human with centchroman, a preliminary report. Fertil Steril 27 (1976) 1108-1110
40. Singh M.M., Bhalla V., Wadhwa V., and Kamboj V.P. Effect of centchroman on tubal transport and preimplantation embryonic development in rats. J Reprod Fert 76 (1986) 317-324
41. Labroo VM, Piggott JR, Bain SD. Methods for reducing bone loss using centchroman derivatives. Zymogenetics, Seattle, WA. US 5,280,040.
42. Piggott JR. 3,4-Diarylchromans for treatment of dermatitis. Zymogenetics, Seattle, WA. US 5,451,603.
43. Bryant HU, Dodge JA. Methods for lowering cholesterol and inhibiting smooth muscle proliferation, restenosis, endometriosis, and uterine fibroid disease. Eli Lilly Indianapolis, IN., US 5,407,955.
44. Williams J.P., McDonald J.M., McKenna M.A., Jordan S.E., Radding W., and Blair H.C. Differential effects of tamoxifen-like compounds on osteoclastic bone degradation, H(+)-ATPase activity, calmodulin-dependent cyclic nucleotide phosphodiesterase activity, and calmodulin binding. J Cell Biochem 66 (1997) 358-369
45. Dwivedi A., Basu R., Chowdhury S.R., and Goyal N. Modulation of estrogen action during preimplantation period and in immature estradiol-primed rat uterus by anti-implantation agent, ormeloxifene. Contraception 71 (2005) 458-464
46. Paliwal J.K., Gupta R.C., Grover P.K., Asthana O.P., Srivastava J.S., and Nityanand S. High-performance liquid chromatography (HPLC) determination of centchroman in human serum, and application to single-dose pharmacokinetics. Pharm Res 6 (1989) 1048-1051
47. Lal J., Paliwal J.K., Grover P.K., and Gupta R.C. Simultaneous liquid chromatographic determination of centchroman and its 7-demethylated metabolite in serum and milk. J Chromatogr Biomed Appl 658 (1994) 193-197
48. Khurana M., Lal J., Kamboj M., Nityanand S., Kamboj V.P., and Gupta R.C. Uptake of centchroman by human uterus. Clin Drug Invest 22 (2002) 715-718
49. Lal J., Asthana O.P., Nityanand S., and Gupta R.C. Pharmacokinetics of centchroman in healthy female subjects after oral administration. Contraception 52 (1995) 297-300
50. Lal J., Nityanand S., Asthana O.P., and Gupta R.C. Comparative bioavailability of two commercial centchroman tablets in healthy female subjects. Indian J Pharmacol 28 (1996) 32-34
51. Gupta R.C., Lal J., Nityanand S., and Asthana O.P. Dose-related differences in serum concentration of centchroman in female volunteers. Proc XXIX Ann Conf Indian Pharmacol Soc, Hyderabad, India (1996)
52. Lal J., Nityanand S., Asthana O.P., and Gupta R.C. Multiple-dose pharmacokinetics of centchroman in female volunteers. Indian J Pharmacol 30 (1998) 120
53. Gupta R.C., Nityanand S., Asthana O.P., and Lal J. Pharmacokinetics of centchroman in nursing women and passage into breast milk. Clin Drug Invest 11 (1996) 305-309
54. Gupta R.C., Nityanand S., Asthana O.P., and Lal J. Centchroman kinetics and disposition into breast milk. Proc 1st Ann Conf Indian Soc Chem Biol, Lucknow, India, 23-24 March (1996) 93-100
55. Khurana M., Paliwal J.K., Kamboj V.P., and Gupta R.C. Binding of centchroman as determined by charcoal adsorption method. Int J Pharm 197 (1999) 109-114
56. Ratna S., Chandra G., Ray S., and Roy S.K. Centchroman: binding with plasma proteins of rat, rabbit, guinea pig, and rhesus monkey. Drug Dev Res 24 (1991) 285-291
57. Agnihotri A., Srivastava A.K., and Kamboj V.P. Characterization of centchroman binding protein in plasma of rhesus monkey (Macaca mulatta). J Med Primatol 25 (1996) 53-56
58. Srivastava A.K., Agnihotri A., and Kamboj V.P. Binding of centchroman-a nonsteroidal antifertility agent in human plasma proteins. Experientia 40 (1984) 465-466
59. Lal J., Nityanand S., Asthana O.P., Nagaraja N.V., and Gupta R.C. Optimization of contraceptive dosage regimen of centchroman. Contraception 63 (2001) 47-51
60. Paliwal J.K., and Gupta R.C. Tissue distribution and pharmacokinetics of centchroman a new nonsteroidal postcoital contraceptive agent and its 7-desmethyl metabolite in female rats after a single oral dose. Drug Metab Dispos 24 (1996) 148-155
61. Khurana M., Lal J., Singh M.M., Paliwal J.K., Kamboj V.P., and Gupta R.C. Evaluation of interaction potential of certain concurrently administered drugs with pharmacological and pharmacokinetic profile of centchroman in rats. Contraception 66 (2002) 47-56
62. Ratna S., Roy S.K., Ray S., et al. Centchroman: in vitro metabolism by rat liver homogenate. Drug Dev Res 7 (1986) 173-178
63. 12C)chroman. J Labelled Compd Radiopharm 16 (1978) 373-376
64. Mishra N.C., Ray S., and Roy S.K. Influence of centchroman on some hepatic microsomal enzymes in female rhesus monkeys. Med Sci Res 18 (1990) 881-882
65. Ganong W.F. Review of Medical Physiology (1985), Lange Medical Publications, California 575
66. Paliwal J.K., Grover P.K., Asthana O.P., Nityanand S., and Gupta R.C. Excretion of centchroman in breast milk. Br J Clin Pharmacol 38 (1994) 485-486
67. Gupta R.C., Paliwal J.K., Nityanand S., Asthana O.P., and Lal J. Centchroman: a new nonsteroidal oral contraceptive in human milk. Contraception 52 (1995) 301-305
68. Atkinson H.C., Begg E.J., and Darlow B.A. Guide to safety of drugs in human milk. Clinical Pharmacokinetics Drug Data Handbook 4 (1990), Adis Press, Sydney 125-164
69. Khurana M., Lal J., Kamboj V.P., Nityanand S., and Gupta R.C. Pharmacokinetic interaction of tetracycline with centchroman in healthy female volunteers. Drugs R D 4 (2003) 293-299